While the dollar amount is small relative to market cap, the coordinated timing and C-suite level of both sellers may signal caution ahead of upcoming earnings or strategic challenges, particularly given AbbVie's reliance on post-Humira revenue transition.
Price Chart
Executive Summary
Two AbbVie executives — SVP and EVP — each sold shares in the open market, totaling approximately $2.57 million in proceeds. Both transactions were open-market sales at prevailing prices, with no indication of forced or non-cash dispositions.
Key Financial Metrics
Key Facts
- SVP David Ryan sold 5,230 shares for $1,221,518.80 at $233.56 per share on March 4, 2026
- EVP Perry Siatis sold 5,777 shares for $1,348,987.27 at $233.51 per share on March 2, 2026
- Total open-market sales: $2,570,506.07 across two C-suite executives
- Sales represent 0.00063% of AbbVie's $410.8B market cap
Financial Impact
$2.57 million in open-market sales by two senior executives
Risk Factors
- Perception of insider pessimism despite routine nature of small sales
- Potential for negative market interpretation given lack of offsetting insider buying
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-ABBV-1772834780269 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | Court Ruling | $261.77 $264.48 | ▲ +1.04% | ▼ −0.62% | $260.37 (−0.53%) |
Sep 3, 2026 29d ago | 8-K | $260.21 $257.12 | ▼ −1.19% | ▼ −0.04% | $260.37 (+0.06%) |
Aug 5, 2026 8w ago | 8-K | $243.87 $250.82 | ▲ +2.85% | ▲ +1.64% | $260.37 (+6.77%) |
Aug 3, 2026 8w ago | Institutional Cluster | $245.10 $247.97 | ▲ +1.17% | ▼ −0.86% | $260.37 (+6.23%) |
Aug 3, 2026 8w ago | Court Ruling | $245.10 $247.97 | ▲ +1.17% | ▼ −0.86% | $260.37 (+6.23%) |
Jul 31, 2026 9w ago | 8-K | $250.94 $246.04 | ▼ −1.95% | ▼ −5.46% | $260.37 (+3.76%) |
Jul 27, 2026 9w ago | Court Ruling | $256.91 $250.94 | ▼ −2.32% | ▼ −3.40% | $260.37 (+1.35%) |
Jun 22, 2026 14w ago | 8-K | $230.01 $254.31 | ▲ +10.56% | ▲ +11.02% | $260.37 (+13.20%) |
May 18, 2026 19w ago | Court Ruling | $209.41 $213.12 | ▲ +1.77% | ▲ +0.15% | $260.37 (+24.34%) |
Apr 29, 2026 22w ago | 8-K | $203.89 $206.11 | ▲ +1.09% | ▼ −2.02% | $260.37 (+27.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access